The Baxter Group is a diversified investing and operating company focused on life-sciences, healthcare, technology, and real-estate.

INITIATE co-creates and funds companies boldly revitalizing healthcare.

Founding team member and first day-to-day executive responsible for all business operations, including business development, finance, strategy, talent, marketing, legal, IT and facilities.Built and recruited a team of 80 across all functional departments, including key leadership (CEO, COO, GC, SVP of R&D, VP of Product, VP of Talent).Led strategy, pitch, and diligence of Seed, Series A, and Series B rounds totalling more than $150M in equity capital raised.Closed multi-asset block-buster deal with Takeda Pharmaceuticals and negotiated company’s first business development deals across biopharma, industrials, and synthetic biology.Established and expanded initial R&D partnership with NVIDIA to advance deep learning models.

Senior executive responsible for deal generation, deal diligence, deal prosecution, and support of $1B+ Paragon portfolio companies with key strategic initiatives.Sourced founding technology, negotiated license agreement with University of Chicago, and served as founding operating partner for Paragon’s incubation of Evozyne.Served as key strategic and operational partner to Paragon’s other successful clinical-stage biopharmaceutical companies.

Negotiated and closed more than 40 strategic business development deals with leading national health plans, pharmacy benefit managers, dental payers, and behavioral health providers. Business development efforts resulted in expanding Castlight’s market share by a significant percentage.

Led marketing and sales launch plan for company’s portfolio of diagnostic products, resulting in successful launch of company’s flagship product, VECTRA-DA. Company was ultimately acquired by Myriad Genetics.